Omega Healthcare Investors (OHI) FY2020 results: revenue $892 million, down 3.9% on the year
Omega Healthcare Investors Inc. (OHI) reported revenue of $892 million for fiscal 2020, the year ended 31 December 2020, down 3.9% on the year before. Net income was $159 million, down 53.3%, and diluted earnings per share $0.70. The figures are the company's own, from the 10-K it filed with the SEC on 22 February 2021.
Revenue
$892 million
-3.9% on the year
FY2013FY2020
Operating margin
17.6%
59.4% a year earlier
FY2013FY2020
Net income
$159 million
-53.3% on the year
FY2013FY2020
Diluted EPS
$0.70
-55.7% on the year
FY2013FY2020
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Revenue
892
929
882
-3.9%
Operating income
157
552
498
-71.5%
Operating margin
17.6%
59.4%
56.4%
Interest expense
223
209
192
+7.0%
Pre-tax income
162
344
297
-52.8%
Income tax
4.9
2.8
3.0
+73.2%
Effective tax rate
3.0%
0.8%
1.0%
Net income
159
341
282
-53.3%
Net margin
17.9%
36.7%
31.9%
Diluted EPS
$0.70
$1.58
$1.40
-55.7%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Operating cash flow
708
554
499
+27.9%
Capital expenditure
31.1
52.9
29.8
-41.3%
Free cash flow
677
501
470
+35.2%
Free cash flow margin
75.9%
53.9%
53.3%
Cash from investing
-89.1
-379
-173
Cash from financing
-486
-154
-411
Depreciation and amortisation
330
302
281
+9.4%
Share-based compensation
18.8
15.4
16.0
+22.5%
Dividends paid
612
564
529
+8.5%
Dividend per share
$2.68
$2.65
$2.64
+1.1%
Diluted shares, weighted
235m
222m
210m
+5.8%
Shares outstanding at period end
231m
227m
202m
+2.0%
Balance sheet
$ million
FY2020
FY2019
FY2018
On the year
Last 8 years
Shareholders' equity
3,842
4,135
3,444
-7.1%
Non-controlling interest
195
201
320
-3.2%
Debt
5,169
5,136
4,541
+0.6%
Other liabilities
292
323
286
-9.8%
Total liabilities and equity
9,497
9,796
8,591
-3.0%
Goodwill
652
644
644
+1.1%
Intangible assets
1.9
28.0
n/a
-93.1%
Cash and equivalents
164
24.1
10.3
+578.1%
Other assets
8,680
9,100
7,937
-4.6%
Total assets
9,497
9,796
8,591
-3.0%
10-K for the year ended 31 December 2020, filed 22 February 2021: the filing.